2023 Q4 Form 10-Q Financial Statement

#000189879523000169 Filed on November 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $15.09M $8.144M $3.748M
YoY Change 63.71% 117.27%
Cost Of Revenue $20.28M $7.052M $13.74M
YoY Change 192.12% -48.69% 56.17%
Gross Profit -$5.188M $1.092M -$9.995M
YoY Change -327.94% -110.93% 464.67%
Gross Profit Margin -34.38% 13.41% -266.64%
Selling, General & Admin $28.57M $26.44M $21.99M
YoY Change -6.24% 20.22% 43.24%
% of Gross Profit 2420.79%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.018M $1.440M $3.717M
YoY Change 341.23% -61.26% 190.39%
% of Gross Profit 131.87%
Operating Expenses $28.57M $26.44M $3.367M
YoY Change -6.24% 685.04% 8.03%
Operating Profit -$33.75M -$25.34M -$3.367M
YoY Change 19.74% 652.61% 8.03%
Interest Expense $2.365M $2.730M -$3.000K
YoY Change 94.81% -91100.0% -110.38%
% of Operating Profit
Other Income/Expense, Net -$1.688M $0.00 $7.260M
YoY Change -133.54% -100.0% -15.28%
Pretax Income -$33.08M -$14.58M -$20.95M
YoY Change 50.74% -30.4% -429.0%
Income Tax $15.00K -$1.000K -$4.000K
% Of Pretax Income
Net Earnings -$33.09M -$14.58M $3.892M
YoY Change 52.14% -474.54% -28.61%
Net Earnings / Revenue -219.29% -179.0% 103.84%
Basic Earnings Per Share -$0.07 $0.01
Diluted Earnings Per Share -$0.16 -$0.07 $0.01
COMMON SHARES
Basic Shares Outstanding 202.5M shares 202.5M shares 161.0M shares
Diluted Shares Outstanding 202.5M shares 45.91M

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $167.9M $199.9M $2.168M
YoY Change -36.69% 9120.48% 98.76%
Cash & Equivalents $167.9M $199.9M $240.3K
Short-Term Investments
Other Short-Term Assets $3.004M $1.946M $100.9M
YoY Change -35.05% -98.07% 29476.85%
Inventory $32.12M $32.79M $33.61M
Prepaid Expenses $1.905M $22.92K
Receivables $7.697M $5.200M $3.798M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $210.7M $239.9M $140.5M
YoY Change -30.21% 70.76% 9711.88%
LONG-TERM ASSETS
Property, Plant & Equipment $37.68M $37.69M $26.49M
YoY Change 19.37% 42.27%
Goodwill $8.327M $8.327M
YoY Change 0.0%
Intangibles $1.347M $1.463M
YoY Change -25.54%
Long-Term Investments
YoY Change
Other Assets $6.192M $6.319M $3.011M
YoY Change 22.76% 109.86%
Total Long-Term Assets $55.42M $56.02M $262.1M
YoY Change 11.12% -78.63% -34.51%
TOTAL ASSETS
Total Short-Term Assets $210.7M $239.9M $140.5M
Total Long-Term Assets $55.42M $56.02M $262.1M
Total Assets $266.1M $295.9M $402.6M
YoY Change -24.35% -26.5% 0.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.29M $25.50M $17.62M
YoY Change 272.62% 44.69%
Accrued Expenses $21.19M $18.49M $15.24M
YoY Change 4.16% 21.38% 383.75%
Deferred Revenue $214.0K $428.0K
YoY Change 31.29%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $46.27M $45.40M $134.0M
YoY Change 34.33% -66.11% 483.05%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $814.0K $397.0K $5.363M
YoY Change 230.89% -92.6% -59.14%
Total Long-Term Liabilities $814.0K $397.0K $5.363M
YoY Change 230.89% -92.6% -59.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $46.27M $45.40M $134.0M
Total Long-Term Liabilities $814.0K $397.0K $5.363M
Total Liabilities $60.28M $57.41M $402.2M
YoY Change 33.95% -85.73% 1014.09%
SHAREHOLDERS EQUITY
Retained Earnings -$132.0M -$98.90M -$30.46M
YoY Change 488.23% 224.72%
Common Stock $20.00K $20.00K $1.140K
YoY Change 0.0% 1654.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $205.9M $238.5M $452.0K
YoY Change
Total Liabilities & Shareholders Equity $266.1M $295.9M $402.6M
YoY Change -24.35% -26.5% 0.24%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$33.09M -$14.58M $3.892M
YoY Change 52.14% -474.54% -28.61%
Depreciation, Depletion And Amortization $3.018M $1.440M $3.717M
YoY Change 341.23% -61.26% 190.39%
Cash From Operating Activities -$27.59M -$14.68M -$63.50M
YoY Change 8.22% -76.88% 45478.24%
INVESTING ACTIVITIES
Capital Expenditures $2.492M $2.790M $8.927M
YoY Change -51.65% -68.75% 134.3%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.492M -$2.790M -$8.927M
YoY Change -51.65% -68.75% 134.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.966M 1.550M 172.6M
YoY Change -101.01% -99.1% 824.07%
NET CHANGE
Cash From Operating Activities -27.59M -14.68M -63.50M
Cash From Investing Activities -2.492M -2.790M -8.927M
Cash From Financing Activities -1.966M 1.550M 172.6M
Net Change In Cash -32.04M -15.92M 100.2M
YoY Change -119.65% -115.89% -72013.86%
FREE CASH FLOW
Cash From Operating Activities -$27.59M -$14.68M -$63.50M
Capital Expenditures $2.492M $2.790M $8.927M
Free Cash Flow -$30.08M -$17.47M -$72.43M
YoY Change -1.85% -75.88% 1733.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
23516000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
36987000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
81650000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
56706000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
33487000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
35731000 usd
us-gaap Costs And Expenses
CostsAndExpenses
105166000 usd
us-gaap Costs And Expenses
CostsAndExpenses
93693000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-25343000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-21023000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-82234000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-56078000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
79000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
235000 usd
CY2023Q3 lvwr Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
8038000 usd
CY2022Q3 lvwr Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
0 usd
lvwr Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-2332000 usd
lvwr Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
0 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3128000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1809000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5044000 usd
CY2022Q4 us-gaap Assets
Assets
351805000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20343000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1312000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
34443000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1913000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15000 usd
CY2022Q4 lvwr Warrant Liabilities
WarrantLiabilities
8388000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
45005000 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
202544000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
19925000 usd
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
246000 usd
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
202544000 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
20000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
337420000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
329218000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-98895000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22438000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
238538000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
306800000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
295946000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
351805000 usd
us-gaap Net Income Loss
NetIncomeLoss
-76457000 usd
us-gaap Net Income Loss
NetIncomeLoss
-56500000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2814000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3717000 usd
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
0 usd
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
413000 usd
lvwr Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-2332000 usd
lvwr Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
6566000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
-171000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
45000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
99000 usd
lvwr Deferred Income Tax Expense Benefit Net Of Reverse Capitalization Adjustments
DeferredIncomeTaxExpenseBenefitNetOfReverseCapitalizationAdjustments
63000 usd
lvwr Deferred Income Tax Expense Benefit Net Of Reverse Capitalization Adjustments
DeferredIncomeTaxExpenseBenefitNetOfReverseCapitalizationAdjustments
68000 usd
us-gaap Inventory Write Down
InventoryWriteDown
1664000 usd
us-gaap Inventory Write Down
InventoryWriteDown
702000 usd
lvwr Capitalization Of Cloud Computing Arrangements
CapitalizationOfCloudComputingArrangements
470000 usd
lvwr Capitalization Of Cloud Computing Arrangements
CapitalizationOfCloudComputingArrangements
2822000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
677000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
209000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2313000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3465000 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
128000 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
466000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5238000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
17518000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2679000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2615000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2149000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3243000 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
15393000 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-55876000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-64190000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10970000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8927000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10970000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8927000 usd
lvwr Deposit In Advance Of Business Combination
DepositInAdvanceOfBusinessCombination
0 usd
lvwr Deposit In Advance Of Business Combination
DepositInAdvanceOfBusinessCombination
100000000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1554000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
15333000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1767000 usd
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
0 usd
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
59051000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1554000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
172617000 usd
CY2023Q3 us-gaap Cash
Cash
199948000 usd
CY2022Q3 us-gaap Cash
Cash
2168000 usd
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
100000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
199948000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
102168000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
306800000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21147000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1824000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
287477000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-40732000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2378000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
6000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
249129000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-14578000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2364000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1630000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
238538000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-15979000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-100000 usd
CY2022Q1 lvwr Net Contributions From Parent
NetContributionsFromParent
19051000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
22897000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-19578000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6000 usd
CY2022Q2 lvwr Net Contributions From Parent
NetContributionsFromParent
34060000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
37385000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-20943000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-60000 usd
CY2022Q3 lvwr Net Contributions From Parent
NetContributionsFromParent
26811000 usd
CY2022Q3 lvwr Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
1
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
161000000 shares
CY2022Q3 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
200000000 usd
CY2022Q3 lvwr Proceeds From Reverse Capitalization Transaction
ProceedsFromReverseCapitalizationTransaction
293700000 usd
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
202402888 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
202402888 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
202529000 shares
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8144000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14708000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22932000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
37615000 usd
CY2022Q3 lvwr Variable Consideration Related To Previously Recognized Sales
VariableConsiderationRelatedToPreviouslyRecognizedSales
0 usd
CY2023Q3 lvwr Variable Consideration Related To Previously Recognized Sales
VariableConsiderationRelatedToPreviouslyRecognizedSales
0 usd
lvwr Variable Consideration Related To Previously Recognized Sales
VariableConsiderationRelatedToPreviouslyRecognizedSales
0 usd
lvwr Variable Consideration Related To Previously Recognized Sales
VariableConsiderationRelatedToPreviouslyRecognizedSales
0 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
428000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
163000 usd
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
233000 usd
lvwr Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
163000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1644000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
428000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.003
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-14578000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-20943000 usd
us-gaap Net Income Loss
NetIncomeLoss
-76457000 usd
us-gaap Net Income Loss
NetIncomeLoss
-56500000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
202529000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
161000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
202448000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
161000000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
161000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
202448000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
161000000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
161000000 shares
CY2022Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
161000000 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q3 us-gaap Inventory Work In Process And Raw Materials Net Of Reserves
InventoryWorkInProcessAndRawMaterialsNetOfReserves
1259000 usd
CY2022Q4 us-gaap Inventory Work In Process And Raw Materials Net Of Reserves
InventoryWorkInProcessAndRawMaterialsNetOfReserves
48000 usd
CY2023Q3 lvwr Inventory Parts And Accessories And Apparel Net Of Reserves
InventoryPartsAndAccessoriesAndApparelNetOfReserves
3079000 usd
CY2022Q4 lvwr Inventory Parts And Accessories And Apparel Net Of Reserves
InventoryPartsAndAccessoriesAndApparelNetOfReserves
3876000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
32789000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
29215000 usd
CY2023Q3 lvwr Accrued Capital Expenditures Current
AccruedCapitalExpendituresCurrent
5371000 usd
CY2023Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
6015000 usd
CY2023Q3 lvwr Accrued Engineering Current
AccruedEngineeringCurrent
3391000 usd
CY2022Q4 lvwr Accrued Capital Expenditures Current
AccruedCapitalExpendituresCurrent
7748000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
4641000 usd
CY2022Q4 lvwr Accrued Engineering Current
AccruedEngineeringCurrent
4377000 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
30499990 shares
CY2023Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1 shares
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2023Q3 lvwr Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
8038000 usd
lvwr Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-2332000 usd
CY2023Q3 lvwr Warrant Liabilities
WarrantLiabilities
10631000 usd
CY2022Q4 lvwr Warrant Liabilities
WarrantLiabilities
8388000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
562000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
55000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
543000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
160000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
638000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
99000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
246000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
205000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
588000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss
0 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-34000 usd
us-gaap Standard Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss
0 usd
us-gaap Standard Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-77000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
0 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
64000 usd
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-3000 usd
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
188000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
518000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1256000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
518000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1256000 usd
CY2022Q3 us-gaap Manufacturing Costs
ManufacturingCosts
594000 usd
us-gaap Manufacturing Costs
ManufacturingCosts
3402000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
995000 usd
us-gaap Operating Expenses
OperatingExpenses
2702000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-21023000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-82234000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-56078000 usd
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001898795-23-000169-index-headers.html Edgar Link pending
0001898795-23-000169-index.html Edgar Link pending
0001898795-23-000169.txt Edgar Link pending
0001898795-23-000169-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lvwr-20230930.htm Edgar Link pending
lvwr-20230930.xsd Edgar Link pending
lvwr-20230930_g1.jpg Edgar Link pending
lvwrexhibit3119-30x20231.htm Edgar Link pending
lvwrexhibit3129-30x20231.htm Edgar Link pending
lvwrexhibit3219-30x2023.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lvwr-20230930_cal.xml Edgar Link unprocessable
lvwr-20230930_def.xml Edgar Link unprocessable
lvwr-20230930_lab.xml Edgar Link unprocessable
lvwr-20230930_pre.xml Edgar Link unprocessable
lvwr-20230930_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending